{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:08:31Z","timestamp":1791871711042,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["2011\/02\/A\/NZ5\/00341"],"award-info":[{"award-number":["2011\/02\/A\/NZ5\/00341"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s11882-017-0685-2","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T07:47:17Z","timestamp":1489132037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract"],"prefix":"10.1007","volume":"17","author":[{"given":"Malgorzata","family":"Pawe\u0142czyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek Leszek","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"key":"685_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","volume":"16","author":"KJ Henrickson","year":"2003","unstructured":"Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev. 2003;16:242\u201364.","journal-title":"Clin Microbiol Rev"},{"key":"685_CR2","doi-asserted-by":"crossref","unstructured":"Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis. 1991;(Suppl 6):S454\u201362.","DOI":"10.1093\/clinids\/13.Supplement_6.S454"},{"issue":"4","key":"685_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.283.4.499","volume":"283","author":"WP Glezen","year":"2000","unstructured":"Glezen WP, Greenberg SB, Atmar RL, et al. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283(4):499\u2013505.","journal-title":"JAMA"},{"issue":"4","key":"685_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1398-9995.2010.02505.x","volume":"66","author":"NG Papadopoulos","year":"2011","unstructured":"Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria in acute asthma exacerbations\u2014a GA2 LEN-DARE systematic review. Allergy. 2011;66(4):458\u201368.","journal-title":"Allergy"},{"key":"685_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/513975","volume":"175","author":"G Reed","year":"1997","unstructured":"Reed G, Jewett PH, Thompson J, et al. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 year old. The Journal of Infectious Diseases. 1997;175:807\u201313.","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"685_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4161\/hv.1.1.1424","volume":"1","author":"MS Lee","year":"2005","unstructured":"Lee MS, Walker RE, Mendelman PM. Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials. Hum Vaccin. 2005;1(1):6\u201311.","journal-title":"Hum Vaccin"},{"key":"685_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2013.00278","volume":"4","author":"H Tsukagoshi","year":"2013","unstructured":"Tsukagoshi H, Ishioka T, Noda M, et al. Molecular epidemiology of respiratory viruses in virus-induced asthma. Front Microbiol. 2013;4:1\u201310.","journal-title":"Front Microbiol"},{"key":"685_CR8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1086\/507638","volume":"43","author":"AM Fry","year":"2006","unstructured":"Fry AM, Curns AT, Harbour K, et al. Seasonal trends of human parainfluenza viral infections: United States, 1990\u20132004. Clin Infect Dis. 2006;43:1016\u201322.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"685_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1023\/A:1007511018330","volume":"15","author":"H Laurichesse","year":"1999","unstructured":"Laurichesse H, Dedman D, Watson JM, et al. Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. Eur J Epidemiol. 1999;15(5):475\u201384.","journal-title":"Eur J Epidemiol"},{"key":"685_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/infdis\/jit552","volume":"209","author":"HM Frost","year":"2014","unstructured":"Frost HM, Robinson CC. Dominguez epidemiology and clinical presentation of parainfluenza type 4 in children: a 3-year comparative study to parainfluenza types 1\u20133. JID. 2014;209:695\u2013702.","journal-title":"JID"},{"issue":"2","key":"685_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5501\/wjv.v2.i2.57","volume":"2","author":"M Audsley","year":"2013","unstructured":"Audsley M, Moseley GW. Paramyxovirus evasion of innate immunity: diverse strategies for common targets. World J Virol. 2013;2(2):57\u201370.","journal-title":"World J Virol"},{"issue":"2","key":"685_CR12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.72.2.891-899.1998","volume":"72","author":"D Kolakofsky","year":"1998","unstructured":"Kolakofsky D, Pelet T, Garcin D, et al. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol. 1998;72(2):891\u20139.","journal-title":"J Virol"},{"issue":"5","key":"685_CR13","doi-asserted-by":"publisher","first-page":"e00803","DOI":"10.1128\/mBio.00803-13","volume":"4","author":"R Xu","year":"2013","unstructured":"Xu R, Palmer SG, Porotto M, et al. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo. MBio. 2013;4(5):e00803\u201313.","journal-title":"MBio"},{"key":"685_CR14","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1016\/j.jmb.2013.09.015","volume":"425","author":"G Parks","year":"2013","unstructured":"Parks G, Alexander-Miller MA. Paramyxovirus activation and inhibition of innate immune responses. J Mol Biol. 2013;425:4872\u201392.","journal-title":"J Mol Biol"},{"issue":"7","key":"685_CR15","doi-asserted-by":"publisher","first-page":"e1000155","DOI":"10.1371\/journal.pbio.1000155","volume":"7","author":"L Zhang","year":"2009","unstructured":"Zhang L, Button B, Gabriel SE, et al. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. PLoS Biol. 2009;7(7):e1000155.","journal-title":"PLoS Biol"},{"issue":"2","key":"685_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.virol.2012.08.027","volume":"433","author":"A Schaap-Nutt","year":"2012","unstructured":"\u2022 Schaap-Nutt A, Liesman R, Bartlett EJ, et al. Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium. Virology. 2012;433(2):320\u20138. Comparison of replication kinetics and cytokine release by different hPIV serotypes and description of serotype-specific clinical manifestation of infections.","journal-title":"Virology"},{"issue":"3","key":"685_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3727\/000000001783992641","volume":"9","author":"J Gao","year":"2000","unstructured":"Gao J, Choudhary S, Banerjee AK, et al. Human parainfluenza virus type 3 upregulates ICAM-1 (CD54) expression in a cytokine-independent manner. Gene Expr. 2000;9(3):115\u201321.","journal-title":"Gene Expr"},{"key":"685_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12950-015-0054-7","volume":"12","author":"A Lewandowska-Polak","year":"2015","unstructured":"\u2022\u2022 Lewandowska-Polak A, Brauncajs M, Paradowska E, et al. Human parainfluenza virus type 3 (HPIV3) induces production of IFN\u03b3 and RANTES in human nasal epithelial cells (HNECs). J Inflamm. 2015;12:16. hPIV-3 infection of human airway epithelial cell line may induce expression and release of interferon gamma, which may contribute to local antiviral defense.","journal-title":"J Inflamm"},{"key":"685_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2010.00124","volume":"1","author":"M Yoshizumi","year":"2010","unstructured":"\u2022\u2022 Yoshizumi M, Kimura H, Okayama Y, et al. Relationships between cytokine profiles and signaling pathways (I\u03baB kinase and p 38 MAPK) in parainfluenza virus-infected lung fibroblasts. Front Microbiol. 2010;1:1\u20137. hPIV-induced generation of several proinflammatory (IL-1\u03b2, IL-6, TNF-\u03b1) and tissue remodeling-related cytokines (PDGF and VEGF) has been suggested to contribute to the prolonged airway inflammation and airway structural changes typical of asthma.","journal-title":"Front Microbiol"},{"issue":"1","key":"685_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/ije\/24.1.223","volume":"24","author":"E Omenaas","year":"1995","unstructured":"Omenaas E, Bakke P, Haukenes G, et al. Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. Int J Epidemiol. 1995;24(1):223\u201331.","journal-title":"Int J Epidemiol"},{"issue":"14","key":"685_CR21","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1073\/pnas.91.14.6293","volume":"91","author":"S Sieg","year":"1994","unstructured":"Sieg S, Muro-Cacho C, Robertson S, et al. Infection and immunoregulation of T lymphocytes by parainfluenza virus type 3. Proc Natl Acad Sci U S A. 1994;91(14):6293\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"685_CR22","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1128\/jvi.70.7.4845-4848.1996","volume":"70","author":"S Sieg","year":"1996","unstructured":"Sieg S, King C, Huang Y, et al. The role of interleukin-10 in the inhibition of T-cell proliferation and apoptosis mediated by parainfluenza virus type 3. J Virol. 1996;70(7):4845\u20138.","journal-title":"J Virol"},{"issue":"14","key":"685_CR23","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1128\/JVI.00153-09","volume":"83","author":"JP Parisien","year":"2009","unstructured":"Parisien JP, Bamming D, Komuro A, et al. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J Virol. 2009;83(14):7252\u201360.","journal-title":"J Virol"},{"issue":"21","key":"685_CR24","doi-asserted-by":"publisher","first-page":"14269","DOI":"10.1074\/jbc.M710089200","volume":"283","author":"LL Lu","year":"2008","unstructured":"Lu LL, Puri M, Horvath CM, et al. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappa B kinase epsilon (IKKe)\/TBK1. J Biol Chem. 2008;283(21):14269\u201376.","journal-title":"J Biol Chem"},{"issue":"23","key":"685_CR25","doi-asserted-by":"publisher","first-page":"14756","DOI":"10.1128\/JVI.79.23.14756-14768.2005","volume":"79","author":"M Nishio","year":"2005","unstructured":"Nishio M, Tsurudome M, Ito M, et al. Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect. J Virol. 2005;79(23):14756\u201368.","journal-title":"J Virol"},{"issue":"2","key":"685_CR26","doi-asserted-by":"publisher","first-page":"e28382","DOI":"10.1371\/journal.pone.0028382","volume":"7","author":"H Schomacker","year":"2012","unstructured":"Schomacker H, Hebner RM, Boonyaratanakornkit J, et al. The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining stat 1 in perinuclear aggregates at the late endosome. PLoS One. 2012;7(2):e28382.","journal-title":"PLoS One"},{"key":"685_CR27","doi-asserted-by":"crossref","unstructured":"Tyrrell DA, Bynoe ML. Studies on parainfluenza type 2 and 4 viruses obtained from patients with common colds. Br Med J. 19691:471\u20134.","DOI":"10.1136\/bmj.1.5642.471"},{"key":"685_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2334-13-28","volume":"13","author":"WK Liu","year":"2013","unstructured":"Liu WK, Liu Q, Chen DH, et al. Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infect Dis. 2013;13:28.","journal-title":"BMC Infect Dis"},{"key":"685_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1086\/514137","volume":"176","author":"A Marx","year":"1997","unstructured":"Marx A, Torok TJ, Holman RC, et al. Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis. 1997;176:1423\u20137.","journal-title":"J Infect Dis"},{"issue":"5","key":"685_CR30","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2006-12-060343","volume":"110","author":"AJ Peck","year":"2007","unstructured":"Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood. 2007;110(5):1681\u20138.","journal-title":"Blood"},{"issue":"6","key":"685_CR31","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/jvi.65.6.2773-2777.1991","volume":"65","author":"A Moscona","year":"1991","unstructured":"Moscona A, Peluso RW. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. J Virol. 1991;65(6):2773\u20137.","journal-title":"J Virol"},{"issue":"5","key":"685_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/mpat.1999.0313","volume":"27","author":"C Ah-Tye","year":"1999","unstructured":"Ah-Tye C, Schwartz S, Huberman K, et al. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3. Microb Pathog. 1999;27(5):329\u201336.","journal-title":"Microb Pathog"},{"issue":"7","key":"685_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ppul.22692","volume":"48","author":"M Ruotsalainen","year":"2013","unstructured":"Ruotsalainen M, Hyv\u00e4rinen MK, Piippo-Savolainen E, et al. Adolescent asthma after rhinovirus and respiratory syncytial virus bronchiolitis. Pediatr Pulmonol. 2013;48(7):633\u20139.","journal-title":"Pediatr Pulmonol"},{"issue":"11 Suppl","key":"685_CR34","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.1097\/01.inf.0000144674.24802.c1","volume":"23","author":"MJ Holtzman","year":"2004","unstructured":"\u2022 Holtzman MJ, Shornick LP, Grayson MH, et al. \u201cHit-and-run\u201d effects of paramyxoviruses as a basis for chronic respiratory disease. Pediatr Infect Dis J. 2004;23(11 Suppl):S235\u201345. New concept for asthma pathogenesis that includes epithelial, viral and allergic components and proposes viral reprogramming of the host immune response.","journal-title":"Pediatr Infect Dis J"},{"key":"685_CR35","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1086\/516533","volume":"176","author":"KJ Henrickson","year":"1997","unstructured":"Henrickson KJ, Savatski LL. Antigenic structure, function, and evolution of the hemagglutinin-neuraminidase protein of human parainfluenza virus type 1. J Infect Dis. 1997;176:867\u201375.","journal-title":"J Infect Dis"},{"key":"685_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0301-0546(03)79204-0","volume":"31","author":"AM Azevedo","year":"2003","unstructured":"Azevedo AM, Durigon EL, Okasima V, et al. Detection of influenza, parainfluenza, adenovirus and respiratory syncytial virus during asthma attacks in children older than 2 years old. Allergol Immunopathol. 2003;31:311\u20137.","journal-title":"Allergol Immunopathol"},{"key":"685_CR37","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/bmj.307.6910.982","volume":"307","author":"KG Nicholson","year":"1993","unstructured":"Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982\u20136.","journal-title":"BMJ"},{"issue":"6989","key":"685_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","volume":"310","author":"SL Johnston","year":"1995","unstructured":"Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9\u201311 year old children. BMJ. 1995;310(6989):1225\u20139.","journal-title":"BMJ"},{"key":"685_CR39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000088728","volume":"138","author":"H Matsuse","year":"2005","unstructured":"Matsuse H, Kondo Y, Saeki S, et al. Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotriens. Int Arch Allergy Immunol. 2005;138:267\u201372.","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"685_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3345\/kjp.2014.57.1.29","volume":"57","author":"JM Kwon","year":"2014","unstructured":"Kwon JM, Shim JW, Kim DS, et al. Prevalence of respiratory viral infection in children hospitalized for acute lower respiratory tract diseases, and association of rhinovirus and influenza virus with asthma exacerbations. Korean J Pediatr. 2014;57(1):29\u201334.","journal-title":"Korean J Pediatr"},{"key":"685_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/323150","volume":"184","author":"MS Lee","year":"2001","unstructured":"Lee MS, Greenberg DP, Yeh SH, et al. Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants. J Infect Dis. 2001;184:909\u201313.","journal-title":"J Infect Dis"},{"issue":"1","key":"685_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1086\/520142","volume":"29","author":"A Marx","year":"1999","unstructured":"Marx A, Gary Jr HE, Marston BJ, et al. Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clin Infect Dis. 1999;29(1):134\u201340.","journal-title":"Clin Infect Dis"},{"issue":"21","key":"685_CR43","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.3760\/cma.j.issn.0366-6999.20141556","volume":"127","author":"R Zhu","year":"2014","unstructured":"Zhu R, Song Q, Qian Y, et al. Virus profile in children with acute respiratory infections with various severities in Beijing, China. Chin Med J. 2014;127(21):3706\u201311.","journal-title":"Chin Med J"},{"key":"685_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jcv.2014.06.025","volume":"61","author":"WAR Zwaans","year":"2014","unstructured":"Zwaans WAR, Mallia P, van Windena MEC, et al. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease \u2013 a systematic review. J Clin Virol. 2014;61:181\u20138.","journal-title":"J Clin Virol"},{"issue":"2","key":"685_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/00365548.2014.968866","volume":"47","author":"RS Djamin","year":"2015","unstructured":"Djamin RS, Uzun S, Snelders E, et al. Occurrence of virus-induced COPD exacerbations during four seasons. Infect Dis. 2015;47(2):96\u2013100.","journal-title":"Infect Dis"},{"issue":"10","key":"685_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/CS20130130","volume":"125","author":"WR Ford","year":"2013","unstructured":"Ford WR, Blair AE, Evans RL, et al. Human parainfluenza type 3 virus impairs the efficacy of glucocorticoids to limit allergy-induced pulmonary inflammation in guinea-pigs. Clin Sci (Lond). 2013;125(10):471\u201382.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"685_CR47","first-page":"135","volume":"44","author":"I Konstantinidis","year":"2006","unstructured":"Konstantinidis I, Haehner A, Frasnelli J, et al. Post-infectious olfactory dysfunction exhibits a seasonal pattern. Rhinology. 2006;44(2):135\u20139.","journal-title":"Rhinology"},{"key":"685_CR48","first-page":"191","volume":"538","author":"M Sugiura","year":"1998","unstructured":"Sugiura M, Aiba T, Mori J, et al. An epidemiological study of postviral olfactory disorder. Acta Otolaryngol Suppl. 1998;538:191\u20136.","journal-title":"Acta Otolaryngol Suppl"},{"issue":"8","key":"685_CR49","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/MLG.0b013e318063e878","volume":"117","author":"JH Wang","year":"2007","unstructured":"Wang JH, Kwon HJ, Jang YJ. Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients. Laryngoscope. 2007;117(8):1445\u20139.","journal-title":"Laryngoscope"},{"issue":"10","key":"685_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/all.12260","volume":"68","author":"ML Kowalski","year":"2013","unstructured":"Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68(10):219\u201332.","journal-title":"Allergy"},{"issue":"2","key":"685_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1086\/653621","volume":"202","author":"A Moscona","year":"2010","unstructured":"Moscona A, Porotto M, Palmer S, et al. A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo. J Infect Dis. 2010;202(2):234\u201341.","journal-title":"J Infect Dis"},{"issue":"13","key":"685_CR52","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1128\/JVI.00135-10","volume":"84","author":"M Porotto","year":"2010","unstructured":"Porotto M, Yokoyama CC, Palermo LM, et al. Viral entry inhibitors targeted to the membrane site of action. J Virol. 2010;84(13):6760\u20138.","journal-title":"J Virol"},{"issue":"5","key":"685_CR53","doi-asserted-by":"publisher","first-page":"e36833","DOI":"10.1371\/journal.pone.0036833","volume":"7","author":"A Pessi","year":"2012","unstructured":"Pessi A, Langella A, Capit\u00f2 E, et al. A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity. PLoS One. 2012;7(5):e36833.","journal-title":"PLoS One"},{"issue":"4","key":"685_CR54","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0264-410X(95)98266-D","volume":"13","author":"JE Crowe","year":"1995","unstructured":"Crowe JE. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development. Vaccine. 1995;13(4):415\u201321.","journal-title":"Vaccine"},{"issue":"7","key":"685_CR55","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1086\/428092","volume":"191","author":"DP Greenberg","year":"2005","unstructured":"Greenberg DP, Walker RE, Lee MS, et al. A bovineparainfluenza virus type 3 vaccine is safe and immunogenic in early infancy. JInfect Dis. 2005;191(7):1116\u201322.","journal-title":"JInfect Dis"},{"key":"685_CR56","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/00006454-199608000-00003","volume":"15","author":"RA Karron","year":"1996","unstructured":"Karron RA, Makhene M, Gay K. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two-to-six-month old infants. Pediatr Infect Dis J. 1996;15:650\u20134.","journal-title":"Pediatr Infect Dis J"},{"issue":"26","key":"685_CR57","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1016\/j.vaccine.2011.12.022","volume":"30","author":"RA Karron","year":"2012","unstructured":"Karron RA, Thumar B, Schappell E, et al. Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines infants and young children. Vaccine. 2012;30(26):3975\u201381.","journal-title":"Vaccine"},{"issue":"7","key":"685_CR58","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/INF.0b013e318199c3b1","volume":"28","author":"M Gomez","year":"2009","unstructured":"Gomez M, Mufson MA, Dubovsky F, et al. Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratorysyncytial virus and parainfluenza-3 virus in seropositive children. Pediatr Infect Dis J. 2009;28(7):655\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"685_CR59","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1086\/381184","volume":"189","author":"RB Belshe","year":"2004","unstructured":"Belshe RB, Newman FK, Tsai TF, et al. Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live atten-uated vaccine in healthy children 6\u201318 months old. J Infect Dis. 2004;189(3):462\u201370.","journal-title":"J Infect Dis"},{"issue":"2","key":"685_CR60","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1128\/JVI.73.2.1374-1381.1999","volume":"73","author":"MH Skiadopoulos","year":"1999","unstructured":"Skiadopoulos MH, Surman S, Tatem JM, et al. Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine. J Virol. 1999;73(2):1374\u201381.","journal-title":"J Virol"},{"issue":"4","key":"685_CR61","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1055\/s-0031-1283289","volume":"32","author":"AC Schmidt","year":"2011","unstructured":"Schmidt AC. Progress in respiratory virus vaccine development. Semin Respir Crit Care Med. 2011;32(4):527\u201340.","journal-title":"Semin Respir Crit Care Med"},{"issue":"10","key":"685_CR62","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1097\/INF.0b013e31822ea24f","volume":"30","author":"RA Karron","year":"2011","unstructured":"Karron RA, Casey R, Thumar B, et al. The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp 45 is well-tolerated, infectious, and immunogenic in infants and young children. Pediatr Infect Dis J. 2011;30(10):e186\u201391.","journal-title":"Pediatr Infect Dis J"},{"issue":"48","key":"685_CR63","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1016\/j.vaccine.2013.09.046","volume":"31","author":"JA Englund","year":"2013","unstructured":"Englund JA, Karron RA, Cunningham CK, et al. Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children. Vaccine. 2013;31(48):5706\u201312.","journal-title":"Vaccine"},{"key":"685_CR64","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fmicb.2013.00346","volume":"4","author":"K Senchi","year":"2013","unstructured":"Senchi K, Matsunaga S, Hasegawa H, et al. Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3. Front Microbiol. 2013;4:346.","journal-title":"Front Microbiol"},{"issue":"4","key":"685_CR65","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1093\/jpids\/piu104","volume":"4","author":"RA Karron","year":"2015","unstructured":"Karron RA, San Mateo J, Thumar B, et al. Evaluation of a live-attenuated human parainfluenza type 1 vaccine in adults and children. J Pediatric Infect Dis Soc. 2015;4(4):e143\u20136.","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-017-0685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-017-0685-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-017-0685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:58:34Z","timestamp":1744174714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-017-0685-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1007\/s11882-017-0685-2","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"10 March 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Drs. Pawe\u0142czyk and Kowalski declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"16"}}